| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013718 |
| Receipt No. | R000015940 |
| Scientific Title | Clinical evaluation research of GC Implant Aadva |
| Date of disclosure of the study information | 2014/04/15 |
| Last modified on | 2022/05/09 (Ver. 7) |
| Basic information | ||
| Public title | Clinical evaluation research of GC Implant Aadva | |
| Acronym | Clinical evaluation research of GC Implant Aadva | |
| Scientific Title | Clinical evaluation research of GC Implant Aadva | |
| Scientific Title:Acronym | Clinical evaluation research of GC Implant Aadva | |
| Region |
|
|
| Condition | |||
| Condition | single or continuous two teeth loss | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | A study to evaluate the 3 years clinical result of GC Implant Aadva in single or continuous two teeth loss |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | amount of marginal bone loss after implant loading |
| Key secondary outcomes | Evaluation of implant success/survival
Shaking of implant and pain Rubor of peri implant tissue Pus discharge Exposure of implant Oral hygiene |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | A study to evaluate the 3 years clinical result of GC Implant Aadva in single or continuous two teeth loss | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Subjects whom state of loss corresponds to either of condition in the following
Subjects with single or continuous two teeth loss Subjects with 3 unit teeth loss from second primolar to second molar and no dental antagonist at second molar positon 2.Subjects with excellent general status. 3.Subjects with natural or restored medial and distal adjacent teeth to the missing tooth. The condition of the adjacent teeth will not change during this study. 4.Subjects with following bite condition Subjects with A and B1 in Eichner classification Subjects with B2 in Eichner classification and with support zone on the both side 5.Subjects who has dental antagonist irrespective of natural tooth, implant and denture. 6.Subjects with O Leary s Plaque Control score of <20% at screening. 7.Subjects with sufficient bone mass(Bone width 6mm or more of the platform position, Bone height 10mm or more(in lower jow the distance between the mandibular canal)) in the implant placement site. 8.Subjects who sign consent forms to show their agreement to take part in the study 9.Subjects (male and female) aged 20 years or older. |
|||
| Key exclusion criteria | 1.Subjects with a systemic disease that may affect the implant treatment, diabetes for example
2.Subjects with any of the diseases that is contraindicated or relatively contraindicated in oral surgical treatment disorders 3.Subjects with tooth root at planned implantation 4. Subjects with bone graft to the extraction socket 5. Subjects with an untreated tooth that needs endodontic care in an adjacent part of the implant placement site 6. Subjects with a 4-mm or deeper periodontal pocket in an adjacent tooth of the implant placement site 7. Subjects with un-control of periodontal disease 8. Subjects with severe habits of bruxism or clenching 9. Subjects with extremely short intermaxillary distance or notable trismus due to temporomandibular joint dysfunction 10. Subjects with extreme occlusion failure 11. Subjects who smoke more than 10 cigarettes a day or subjects who cannot stop smoking for 2 weeks before and after the implant placement surgery 12. Subjects who plan to participate in other clinical trial, or investigation 30 days prior to or during this study 13. Subjects who are pregnant or nursing or subjects who plan to be pregnant during this study 14. Subjects who cannot understand this study or subjects that the investigator deems ineligible to participate in this study 15. Subjects who can not be mutual understanding or mental illness 16. Uncooperative subjects to treatment 17. Subjects who need sinus lift 18. Subjects with a history of failure of implant placement in the site where an implant is planned to be placed in this study 19. Subjects within 12 weeks of tooth extraction |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kyushu University Faculty of Dental Science | ||||||
| Division name | Implant and Rehabilitative Dentistry | ||||||
| Zip code | |||||||
| Address | 3-1-1 Maidashi Higashi-ku Fukuoka 812-8582, Japan | ||||||
| TEL | 092-642-6376 | ||||||
| koyano@dent.kyushu-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyushu University Faculty of Dental Science | ||||||
| Division name | Implant and Rehabilitative Dentistry | ||||||
| Zip code | |||||||
| Address | 3-1-1 Maidashi Higashi-ku Fukuoka 812-8582, Japan | ||||||
| TEL | 092-642-6441 | ||||||
| Homepage URL | |||||||
| ogino@dent.kyushu-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kyushu University Faculty of Dental Science
Implant and Rehabilitative Dentistry |
| Institute | |
| Department | |
| Funding Source | |
| Organization | GC Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015940 |